Exchange Traded Concepts, LLC Protagonist Therapeutics, Inc Transaction History
Exchange Traded Concepts, LLC
- $7.62 Billion
- Q2 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 47,391 shares of PTGX stock, worth $2.36 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
47,391
Previous 27,392
73.01%
Holding current value
$2.36 Million
Previous $1.32 Million
97.81%
% of portfolio
0.03%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding PTGX
# of Institutions
301Shares Held
61.3MCall Options Held
1.01MPut Options Held
555K-
Farallon Capital Management LLC San Francisco, CA6.11MShares$305 Million1.7% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$287 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.72MShares$285 Million4.53% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.28MShares$213 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3MShares$150 Million5.07% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.45B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...